A combined Covid-19 and flu booster shot from Moderna could be available in some countries by September 2023 at the earliest, CEO Stphane Bancel said.
Speaking at the Davos Agenda, a virtual event being held this week by the World Economic Forum, Bancel said this date was a best case scenario, but that he believed it was possible for some countries next year.

He explained it was a goal for the company to have a single annual booster shot available to avoid compliance issues where people are wary about getting multiple shots every winter.

The US-based company first shared plans to develop a single jab combining its Covid-19 booster with a flu shot back in September, during a presentation to investors.

At the time, Bancel said Moderna could be the first company to bring a high efficacy, pan-respiratory annual booster to market.

The CEO also told Mondays panel that a Moderna Covid-19 vaccine candidate targeting the Omicron variant will enter clinical development in the coming weeks. He added that data on the Omicron-specific jab could be shared with regulators as soon as March.

All rights reserved. 2022. Bizcommunity.com Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an as is and as available basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.